Alzamend Neuro (ALZN) Non Operating Interest Expenses (2020 - 2026)

Alzamend Neuro has disclosed Non Operating Interest Expenses across 7 years of filings, most recently posting $150.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 70.53% year-over-year to $150.0; the TTM figure through Apr 2026 stood at $6619.0 (down 63.29% YoY), while the FY2026 annual figure was $6619.0, down 63.29% from the prior year.
• Non Operating Interest Expenses came in at $150.0 for Q2 2026 at Alzamend Neuro, down from $1337.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $16299.0 in Q1 2022 to a low of $150.0 in Q2 2026.
• Average Non Operating Interest Expenses over 5 years is $3297.2, with a median of $2040.5 recorded in 2023.
• Year-over-year, Non Operating Interest Expenses sank 98.24% in 2022 and jumped 554.28% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $3588.0 in 2022, then rose by 20.15% to $4311.0 in 2023, then decreased by 18.93% to $3495.0 in 2024, then slipped by 24.21% to $2649.0 in 2025, then sank by 94.34% to $150.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $150.0 in Q2 2026, $1337.0 in Q1 2026, and $2649.0 in Q4 2025.